Publikationer 2018

Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF.

Savarese G, Orsini N, Hage C, Vedin O, Cosentino F, Rosano GMC, Dahlström U, Lund LH.

JACC Heart Fail 2018 Mars;6(3):246-256

  06-22-2018

Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.

Savarese G, Sartipy U, Friberg L, Dahlström U, Lund LH

Heart. 2018 Jul;104(13):1093-1100.

  06-22-2018

Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure Patients

Ahmad T, Lund LH,  Rao P,  Ghosh R, Warier P, Vaccaro B, Dahlstrom U, O’Connor CM, Felker GM, Desai NR.

J Am Heart Assoc. 2018 Apr 12;7(8)

  06-25-2018

Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry.

Savarese G, Carrero JJ, Pitt B, Anker SD, Rosano GMC, Dahlström U, Lund LH.

Eur J Heart Fail 2018 Mar 26

  06-22-2018

Effect of expanding evidence and evolving clinical guidelines on the prevalence of indication for cardiac resynchronization therapy in patients with heart failure.

Lund LH, Svennblad B, Dahlström U, Ståhlberg M

European Journal of Heart Failure (2018) 20, 769–777

  06-22-2018

Different relationships between pulse pressure and mortality in heart failure with reduced, mid-range and preserved ejection fraction.

Teng TK, Tay WT, Dahlström U, Benson L, Lam CSP, Lund LH

Int J Cardiol. 2018 Mar 1;254:203-209

  06-22-2018

Comorbidity health pathways in heart failure patients: A sequences-of-regressions analysis using cross-sectional data from 10,575 patients in the Swedish Heart Failure Registry.

Lawson CA, Solis-Trapala I Dahlstrom U, Mamas M, Jaarsma T, Kadam UT, Stromberg A

PLoS Med 2018 Mar 27;15(3)

  06-22-2018

Comorbidities, risk factors and outcomes in patients with heart failure and an ejection fraction of more than or equal to 40% in primary care- and hospital care-based outpatient clinics.

B. Eriksson, P. Wändell, U. Dahlström, P. Näsman, L. H. Lund & M. Edner 

Scandinavian Journal of Primary Health Care, 36:2, 207-215

  06-22-2018

AssociationsWith and Prognostic and Discriminatory Role of N-Terminal Pro–B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction.

Savarese G, Orsini N, Hage C, Dahlström U, Vedin O, Rosano GMC, Lund LH

J Card Fail 2018 Jun;24(6):365-374

  06-22-2018

Association of diuretic treatment at hospital discharge in patients with heart failure with all-cause short- and long-termmortality: A propensity score-matched analysis from SwedeHF.

Paren P, Dahlström U, Edner M, Lappas G, Rosengren A, Schaufelberger M. 

Int J Cardiol. 2018 Apr 15;257:118-124

  06-22-2018